학술논문
P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: FINAL ANALYSIS OF THE DREAMM-2 TRIAL
Document Type
article
Author
Source
HemaSphere, Vol 7, Iss S2, Pp 27-28 (2023)
Subject
Language
English
ISSN
2572-9241